Cat No. K1-00542B

CanCELL HCT-116-FANCG (-/+)*

CanCELL HCT-116-FANCG (-/+) is a human colon adenocarcinoma cell line with a mono-allelic knock-out of the FANCG gene.

CanCELL cell lines are generated by making use of our proprietary TALEN™ technology.

The FANCG TALEN™ binds precisely its recognition site within the FANCG gene, inducing a DSB at this site. This DSB is repaired by nonhomologous end joining (NHEJ). Due to the error-prone nature of NHEJ, a proportion of DSBs will be misrepaired by the addition and/or deletion of nucleotides. These frame shift mutations within the genomic sequence occur at the site of the DSB, resulting in functional disruption of a gene’s activity and therefore achieving gene knock-out.

Benefits

  • Comparable results
    True isogeny: All knock-out mutants are derived from the same parental cell line
  • Convenient and flexible
    Suitable for in vitro and in vivo studies: Allows to keep track of your results – for increased productivity
  • Reliable cell model
    STR analyzed: Authentication and certification of parental and gene edited cell lines

* For Research Use and Compound Testing only (RCT). For Drug Discovery use please contact your local sales representative.

  • Info
  • Content
  • Specifications
Copyright 2012 Cellectis
Design & Development by EtonDigital